Better renal response with daratumumab in patients with monoclonal immunoglobulin deposition disease
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-2194
Abstract: Background: Monoclonal Immunoglobulin deposition disease (MIDD) is characterized by non-amyloidogenic linear amorphous deposition of monoclonal immunoglobulin within the basement membrane of glomeruli, tubules, and blood vessels in the renal parenchyma. The majority of patients with… read more here.
Keywords: diagnosis; daratumumab; deposition; patients monoclonal ... See more keywords
Mitochondrial Diabetes: The Clinical Spectrum of MIDD and MELAS in Association With the A3243G Mutation
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvab048.799
Abstract: Introduction: Maternally inherited diabetes and deafness (MIDD) is a multisystem disorder characterized by insulinopenia and sensorineural hearing loss. This rare form of monogenic diabetes is most commonly associated with the A3243G mutation of mitochondrial DNA… read more here.
Keywords: midd melas; patient; a3243g mutation; midd ... See more keywords